Subscribe to Newsletter

Content by Stephanie Vine:

Discovery & Development Vaccines

Comirnaty for the Community?

| Stephanie Vine

Pfizer-BioNTech COVID-19 vaccine receives full FDA approval.

Business & Regulation Business Practice

Seriously Y'all Stop It

| Stephanie Vine

Pharma wants to empower patients to make informed healthcare decisions, but patients also need to be protected from misinformation.

Business & Regulation Standards & Regulation

Of Medicine and Machine Learning

| Angus Stewart, Stephanie Vine

AI is expanding into medicine. Are the world’s regulators ready?

Business & Regulation Biosimilars

What Lies Ahead for Biosimilars?

| Stephanie Vine

Sandoz’s Pierre Bourdage talks to us about biosimilars and how uptake can be boosted.

Business & Regulation Analytical Science

AI Reunites Pharma with Mother Nature

| Stephanie Vine, Angus Stewart

Can AI facilitate a grand comeback for medicines sourced from Mother Nature?

Business & Regulation Profession

Growing, Adapting, Leading

| Angus Stewart, Stephanie Vine

We interview Mary Lavin, President of Sartorius North America, about her career.

Business & Regulation Standards & Regulation

High Fines for High Prices

| Stephanie Vine

Advanz Pharma is fined for substantially hiking the price of a generic drug.

Business & Regulation Business Practice

Think of the Patients

| Stephanie Vine

GlaxoSmithKline’s Senior Vice President of US Oncology speaks about the pandemic and its impact on patients.

Discovery & Development COVID-19

Battling the Blood Clots

| Stephanie Vine

Why are some COVID-19 vaccines linked to blood clots? Researchers have a theory...

Business & Regulation COVID-19

What Do We Do About Distribution?

| Stephanie Vine

COVID-19 vaccine rollout is a lottery, with some countries faring much better than others.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register